{"title": null, "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2019-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Estudio de tolerancia local de la vacuna antimeningoc\u00f3ccica VA-MENGOC-BC\u00ae en ratas Sprague Dawley. Evaluaci\u00f3n a los 24 y 36 meses en estante / Local tolerance study of the VA-MENGOC-BC\u00ae antimeningococcal vaccine in Sprague Dawley rats. Evaluation at 24 and 36 months of shelf\n[Vaccimonitor (La Habana, Print)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Vaccimonitor (La Habana, Print)); 28(1)ene.-abr. 2019. tab, graf\nArticle Dans Espagnol | LILACS, CUMED | ID: biblio-1094617\nResponsable en Biblioth\u00e8que :\n[CU1.1](http://centros.bvsalud.org/?search=CU1.1&prefix=search&lang=fr)\nRESUMENLa\n[meningitis meningoc\u00f3ccica]continua siendo un problema de [salud]en diferentes pa\u00edses y para la prevenci\u00f3n de esta [enfermedad]se han obtenido diferentes [vacunas]. La [vacuna]VA-MENGOC-BC\u00ae ha constituido ser eficaz y segura en la prevenci\u00f3n de la [meningitis meningoc\u00f3ccica]contra los serogrupos B y C. Esta ha demostrado buena estabilidad en el [tiempo]sin cambiar su calidad como producto; fue conservada a estante durante 24 y 36 meses a temperaturas de 4 a 8 \u00b0C. Se evalu\u00f3 su posible potencial toxicol\u00f3gico a trav\u00e9s de un estudio de [tolerancia]local en [ratas]Sprague Dawley para extender su [vida \u00fatil]. Los [animales]inmunizados se observaron diariamente para evaluar [s\u00edntomas locales]y sist\u00e9micos de [toxicidad]. Se realizaron evaluaciones del [peso corporal], [consumo de agua]y [alimento], [termometr\u00eda], musculometr\u00eda e irritabilidad d\u00e9rmica por el [m\u00e9todo]de Draize. Se realizaron estudios anatomopatol\u00f3gicos peri\u00f3dicos para observar posibles [efectos adversos]. No se observaron [s\u00edntomas]de [toxicidad]ni muertes. No se encontraron diferencias entre los grupos experimentales en cuanto al [peso corporal], el [consumo de agua]y de [alimentos], no se evidenci\u00f3 [fiebre], ni irritabilidad local. Anatomopatol\u00f3gicamente a nivel del punto de inoculaci\u00f3n se observaron procesos granulomatosos de tipo macrof\u00e1gicos caracter\u00edsticos en las [vacunas]que contienen [hidr\u00f3xido de aluminio]. Estos resultados permitieron concluir que la [vacuna]VA-MENGOC-BC\u00ae que permaneci\u00f3 en estante durante 24 y 36 meses no evidenci\u00f3 [efectos adversos]locales, ni sist\u00e9micos en las [ratas](AU)\nABSTRACT\n[Meningococcal meningitis]continues to be a [health]problem in different countries and different [vaccines]have been obtained for the prevention of this [disease]. VA-MENGOC-BC\u00ae [vaccine]has been effective and safe in the prevention of [meningococcal meningitis]against [serogroups]B and C. This has shown good stability over [time]without changing its quality as a product; it was stored on a shelf for 24 and 36 months at [temperatures]of 4 to 8 \u00b0C. Their possible toxicological potential was evaluated through a local tolerance study in [Sprague Dawley rats]. Immunized [animals]were observed daily to evaluate local and systemic [toxicity]symptoms. [Body weight], [water]and [feed intake], [thermometry], musculometry were performed and dermal irritability by the Draize [method]. Anatomopathological studies to observe possible [adverse effects]were made. No symptoms of [toxicity]or deaths were observed. No differences were found between the experimental groups in terms of [body weight], [water]and [food consumption], no [fever]or local irritability was evident. Anatomopathologically no lesions of diagnostic value were observed, at the site of inoculation, granulomatous processes of macrophagic type characteristic in [vaccines]containing [aluminum hydroxide]were observed. These results allowed us to conclude that the VA-MENGOC-BC\u00ae [vaccine]that remained on the shelf for 24 and 36 months did not show any local or systemic effects in [rats](AU)\nTexte int\u00e9gral: Disponible Indice: LILAS (Am\u00e9riques) Sujet Principal: Vaccins antim\u00e9ningococciques / M\u00e9dicaments de R\u00e9f\u00e9rence / M\u00e9ningite \u00e0 m\u00e9ningocoques Limites du sujet: Animaux langue: Espagnol Texte int\u00e9gral: Vaccimonitor (La Habana, Print) Th\u00e8me du journal: Biologie mol\u00e9culaire / \u00c9pid\u00e9miologie / Microbiologie / Vacinas Ann\u00e9e: 2019 Type: Article Pays d'affiliation: Cuba Institution/Pays d'affiliation: Instituto Finlay de Vacunas/CU\nDocuments relatifs \u00e0 ce sujet\nMEDLINE\n...\nLILACS\nLIS", "language": null, "image": null, "pagetype": null, "links": ["#main_container", "#pesquisa", "#footer", "#", "#", "#", "#", "https://politicas.bireme.org/accesibilidad/en/", "https://www.globalindexmedicus.net/fr/", "javascript:change_language('ar')", "javascript:change_language('zh')", "javascript:change_language('en')", "javascript:change_language('fr')", "javascript:change_language('ru')", "javascript:change_language('es')", "javascript:change_language('pt')", "https://pesquisa.bvsalud.org/gim/advanced/?lang=fr", "https://www.globalindexmedicus.net/wp-content/themes/globalindexmedicus/img/guiafr.pdf", "#", "https://www.globalindexmedicus.net/", "https://pesquisa.bvsalud.org/gim/?lang=fr", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Oliva-Hern\u00e1ndez, Reynaldo\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Fari\u00f1as-Medina, Mildrey\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Infante-Bourzac, Juan F\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Hern\u00e1ndez-Salazar, Tamara\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"N\u00fa\u00f1ez-Mart\u00ednez, Darcy\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Quintero-P\u00e9rez, Alex\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Campa-Huergo, Concepci\u00f3n\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Sierra-Gonz\u00e1lez, Gustavo\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Vaccimonitor (La Habana, Print)", "http://centros.bvsalud.org/?search=CU1.1&prefix=search&lang=fr", "https://www.facebook.com/sharer.php?u=https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1094617", "https://twitter.com/intent/tweet?text=Estudio de tolerancia local de la vacuna antimeningoc\u00f3ccica VA-MENGOC-BC\u00ae en ratas Sprague Dawley. Evaluaci\u00f3n a los 24 y 36 meses en estante https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1094617", "https://www.linkedin.com/shareArticle?mini=true&url=https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1094617&title=Estudio de tolerancia local de la vacuna antimeningoc\u00f3ccica VA-MENGOC-BC\u00ae en ratas Sprague Dawley. Evaluaci\u00f3n a los 24 y 36 meses en estante - Index Medicus Global", "https://api.whatsapp.com/send?text=Estudio de tolerancia local de la vacuna antimeningoc\u00f3ccica VA-MENGOC-BC\u00ae en ratas Sprague Dawley. Evaluaci\u00f3n a los 24 y 36 meses en estante - Index Medicus Global - https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1094617", "#mark_ab_es", "#mark_ab_en", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Animaux\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Rats\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Vaccins antim\u00e9ningococciques/usage th\u00e9rapeutique\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"M\u00e9dicaments de R\u00e9f\u00e9rence\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"M\u00e9ningite \u00e0 m\u00e9ningocoques/pr\u00e9vention et contr\u00f4le\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"\u00c9pid\u00e9miologie Exp\u00e9rimentale\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Dermal irritability\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Irritabilidad d\u00e9rmica\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Local tolerance\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Musculometry\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Musculometr\u00eda\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Sprague Dawley\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Sprague Dawley\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Termometr\u00eda\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Thermometry\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Tolerancia local\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"VA-MENGOC-BC\u00ae\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"VA-MENGOC-BC\u00ae\"", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2019000100009", "javascript:window.print()", "javascript:export_xml_record('biblio-1094617');", "https://www.google.com/search?q=\"Estudio de tolerancia local de la vacuna antimeningoc\u00f3ccica VA-MENGOC-BC\u00ae en ratas Sprague Dawley. Evaluaci\u00f3n a los 24 y 36 meses en estante\"", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2019000100009", "javascript:window.print()", "javascript:export_xml_record('biblio-1094617');", "https://www.google.com/search?q=\"Estudio de tolerancia local de la vacuna antimeningoc\u00f3ccica VA-MENGOC-BC\u00ae en ratas Sprague Dawley. Evaluaci\u00f3n a los 24 y 36 meses en estante\"", "https://bvsalud.org/en/contact_us/", "http://politicas.bireme.org/terminos/en/", "http://politicas.bireme.org/privacidad/en/", "javascript:change_output('rss');", "javascript:;", "javascript:print_page();", "javascript:print_page(true);"]}